Rchr
J-GLOBAL ID:201901012492809032   Update date: Apr. 16, 2024

Watanabe Kentaro

ワタナベ ケンタロウ | Watanabe Kentaro
Affiliation and department:
Research field  (3): Tumor biology ,  Fetal medicine/Pediatrics ,  Hematology and oncology
Research theme for competitive and other funds  (3):
  • 2022 - 2024 「がん代謝」を標的とする薬剤と抗がん剤を併用した、神経芽腫の新規治療法の創出
  • 2021 - 2023 「がん代謝」を標的とした、神経芽腫に対する新規治療の創出と抵抗性の克服
  • 2019 - 2021 Multiomics analysis of neuroblastoma searching for novel therapies
Papers (68):
  • Kentaro Watanabe, Keiji Tasaka, Hideto Ogata, Shota Kato, Hiroo Ueno, Katsutsugu Umeda, Tomoya Isobe, Yasuo Kubota, Masahiro Sekiguchi, Shunsuke Kimura, et al. Inhibition of the galactosyltransferase C1GALT1 reduces osteosarcoma cell proliferation by interfering with ERK signaling and cell cycle progression. Cancer Gene Therapy. 2024
  • 小田 啓奈, 井上 秀太郎, 日高 もえ, 関口 昌央, 渡邊 健太郎, 六反 啓文, 牛久 哲男, 吉田 真理子, 渡谷 岳行, 加藤 元博. Turner症候群に巨大腹腔内腫瘍が合併した一例. 日本小児科学会雑誌. 2023. 127. 2. 347-347
  • 渡邉健太郎. 白血病治療中の白質脳症とそのマネジメント. 臨床血液. 2023. 64. 9. 1222-1226
  • Shota Kato, Yoshiko Nakano, Moe Hidaka, Masahiro Sekiguchi, Kentaro Watanabe, Junya Fujimura, Motohiro Kato. Transplantation using targeted busulfan for Diamond-Blackfan anemia. Pediatrics International. 2023. 65. 1
  • Kentaro Watanabe, Shunsuke Kimura, Masafumi Seki, Tomoya Isobe, Yasuo Kubota, Masahiro Sekiguchi, Aiko Sato-Otsubo, Mitsuteru Hiwatari, Motohiro Kato, Akira Oka, et al. Identification of the ultrahigh-risk subgroup in neuroblastoma cases through DNA methylation analysis and its treatment exploiting cancer metabolism. Oncogene. 2022. 41. 46. 4994-5007
more...
MISC (47):
  • 渡邉 健太郎. 【小児・AYAがんの最前線】骨肉腫の分子基盤の探求と標的治療の開発. 医学のあゆみ. 2022. 280. 1. 81-85
  • 渡邉 健太郎. 【研修医と指導医に贈る 小児科学研究・論文のススメ】活躍する小児科physician-scientistsの研究 大学院生編 あなたは大学院に入るべきか?. 小児科診療. 2020. 83. 7. 919-925
  • 渡邉 健太郎. 【小児血液・腫瘍疾患の最前線】研究の最前線 神経芽腫の分子病態. 小児科診療. 2020. 83. 4. 517-521
  • Kentaro Watanabe, Shunsuke Kimura, Masafumi Seki, Tomoya Isobe, Tomoko Kawai, Mitsuteru Hiwatari, Kenichi Yoshida, Yuichi Shiraishi, Kenichi Chiba, Kenichiro Hata, et al. Inhibition of phosphoglycerate dehydrogenase reduces neuroblastoma growth and arginine deiminase expands its application. CANCER SCIENCE. 2018. 109. 249-249
  • Shohei Nakajima, Ami Setoyama, Iori Sato, Tomoko Fukuchi, Harumi Tanaka, Masami Inoue, Kentaro Watanabe, Katsuyoshi Koh, Junko Takita, Mika Tokuyama, et al. Predictors of parental psychological distress during the acute phase of pediatric hematopoietic stem cell transplantation in Japan: A multicenter prospective longitudinal study. BONE MARROW TRANSPLANTATION. 2018. 53. 826-827
more...
Education (2):
  • 2017 - 2021 The University of Tokyo Graduate school of Medicine Department of Pediatrics
  • 2001 - 2007 The University of Tokyo
Professional career (1):
  • 医学博士 (東京大学)
Work history (8):
  • 2021/04 - 現在 Graduate School of Medicine, The University of Tokyo Department of Pediatrics Assistant Professor
  • 2019/04 - 2021/03 Japan Society for the Promotion of Science Research Fellowship for Young Scientists
  • 2017/04 - 2021/03 The University of Tokyo Department of Pediatrics Ward staff
  • 2015/04 - 2017/03 Saitama Children's Medical Center Department of hematology/oncology
  • 2012/04 - 2015/03 University of Tokyo Department of Pediatrics
Show all
Committee career (2):
  • 2022/08 - 現在 日本小児科学会 学術委員会
  • 2016/04 - 現在 JCCG 神経芽腫委員会
Awards (3):
  • 2023/12 - 東京大学小児科医局同窓会 研究奨励賞
  • 2023/08 - JSPHO Academic Award Identification of the ultrahigh-risk subgroup in neuroblastoma cases through DNA methylation analysis and its treatment exploiting cancer metabolism
  • 2018/04 - JAPAN FOUNDATION FOR PEDIATRIC RESERCH JAPAN FOUNDATION FOR PEDIATRIC RESERCH AWARD
Association Membership(s) (5):
Japan Society for Hematopoietic Cell Transplantation ,  THE JAPANESE SOCIETY OF PEDIATRIC HEMATOLOGY/ONCOLOGY ,  THE JAPANESE SOCIETY OF HEMATOLOGY ,  THE JAPANESE CANCER ASSOCIATION ,  JAPAN PEDIATRIC SOCIETY
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page